EUCTR2007-007156-33-GB
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant in Preterm Infants- Dosage study - MIND-Melatonin Neuroprotection Dosage Study
Imperial College0 sites18 target enrollmentMarch 7, 2008
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Imperial College
- Enrollment
- 18
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infants born less than 31 weeks gestation who are less than 7 days old, after parental consent for participation will be included in the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Those with major congenital malformation, or cystic periventricular leucomalacia (cPVL) or haemorrhagic parenchymal infarcts (HPI) on cranial ultrasonography prior to enrolment will be excluded from the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant In Preterm Infants-Trial Study - MINT- Melatonin Neuroprotection Trial Study -Ver 1Brain injury from prematurityMedDRA version: 14.0 Level: LLT Classification code 10013384 Term: Disorders relating to short gestation and unspecified low birthweight System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsEUCTR2008-004740-36-GBImperial College, London60
Completed
Phase 2
MIND: Melatonin Neuroprotection Dosage StudyTopic: Medicines for Children Research NetworkSubtopic: All DiagnosesDisease: All DiseasesInjury, Occupational Diseases, PoisoningBrain injuryISRCTN01115788Imperial College London (UK)24
Completed
Phase 2
Melatonin as a novel neuroprotectant in preterm infants - trial studyBrain injury in premature babiesNeonatal DiseasesUnspecified brain damage due to birth injuryISRCTN15119574Imperial College London (UK)60
Completed
Phase 2
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyPremature BirthBrain InjuryNCT00649961Imperial College London18
Completed
Not Applicable
Oral Melatonin as Neuroprotectant in Preterm InfantsMalondialdehydeMelatoninNCT04235673Francesca Garofoli60